Transgenic R6/1 and R6/2 mouse lines expressing human polyQ-expanded Htt exon 1 (115 and 150 CAG repeats, respectively) under human HTT promoter have proved to be the most popular models to study a mild late-onset or severe juvenile forms of HD, respectively. The gene discussed is HTT; the disease is Huntington disease.